CytomX Therapeutics
CTMX
#9602
Rank
NZ$83.25 M
Marketcap
$1.04
Share price
0.71%
Change (1 day)
-69.49%
Change (1 year)

Earnings for CytomX Therapeutics (CTMX)

Earnings in 2024 (TTM): NZ$11.17 Million

According to CytomX Therapeutics 's latest financial reports the company's current earnings are NZ$0.12 Billion. In 2023 the company made an earning of -NZ$11.33 Million, an increase over its 2022 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CytomX Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$11.17 M-198.68%
2023 -NZ$11.33 Million-94.62%
2022 -NZ$0.22 Billion43.84%
2021 -NZ$0.15 Billion72.37%
2020 -NZ$84.91 Million-52.66%
2019 -NZ$0.18 Billion31.83%
2018 -NZ$0.14 Billion68.34%
2017 -NZ$80.81 Million-20.95%
2016 -NZ$0.11 Billion73.99%
2015 -NZ$58.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.25 Billion-2,229.58%๐Ÿ‡บ๐Ÿ‡ธ USA